Cotización ARS Pharmaceuticals - SPRY

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Último Precio

13.31

Postura de Compra

13.28

Postura de Venta

13.33

Volume Operado de la Acción

141,283

13.01 Rango del Día 13.64

4.64 Rango de 52 semanas 18.49

Capitalización de Mercado [m]

1.294B

Precio Anterior

13.55

Precio de Apertura

13.55

Hora

100

13.31

Última hora de negociación

09:39:27

Volumen financiero

US$ 1,882,122

Precio Promedio Ponderado

13.3216

Volumen promedio (3 m)

1,066,985

Acciones en circulación

97,185,475

Rendimiento del Dividendo

Ratio Precio/Utilidad

-23.70

Beneficio por acción (BPA)

-0.56

turnover

30k

Beneficio neto

-54.37M

ARS Pharmaceuticals Inc is a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis. The company is developing neffy, an intranasal epinephrine product in clinical development for pa... ARS Pharmaceuticals Inc is a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis. The company is developing neffy, an intranasal epinephrine product in clinical development for patients and their caregivers with Type I allergic reactions including food, medications, and insect bites that could lead to life-threatening anaphylaxis. Mostrar más

Sector

Pharmaceutical Preparations

Industria

Pharmaceutical Preparations

Sitio web

ars-pharma.com

Sede

Wilmington, Delaware, USA

Fundado

ARS Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SPRY. The last closing price for ARS Pharmaceuticals was US$13.55. Over the last year, ARS Pharmaceuticals shares have traded in a share price range of US$ 4.64 to US$ 18.49.

ARS Pharmaceuticals currently has 97,185,475 shares in issue. The market capitalisation of ARS Pharmaceuticals is US$1.32 billion. ARS Pharmaceuticals has a price to earnings ratio (PE ratio) of -23.70.

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

ARS Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates

Commercial launch of neffy® (epinephrine nasal spray) underway in the United StatesSupplemental NDA for neffy®1mg dose granted priority review by FDA; PDUFA target date set for March 6...

Form 8-K - Current report

ARS Pharmaceuticals Announces Exclusive Agreement with Global Allergy Leader ALK to Commercialize neffy® in Europe, Canada and Other Geographies Outside the United States

Agreement leverages ALK’s global footprint in developing and commercializing innovative allergy products ARS Pharma to receive an upfront cash payment of $145 million, with total deal...

ARS Pharmaceuticals Announces Conference Call and Webcasts for its Third Quarter 2024 Financial Results and Presentations at Upcoming Conferences

SAN DIEGO, Nov. 06, 2024 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect...

ARS Pharmaceuticals Showcases Intranasal Epinephrine Data at 2024 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting

SAN DIEGO, Oct. 24, 2024 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect...

Form 4 - Statement of changes in beneficial ownership of securities

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	-1.455	-9.85438537081	14.765	15.25	13.01	1317724	13.88580152	CS
4	-2.81	-17.4317617866	16.12	18.49	13.01	1290991	15.20687135	CS
12	-0.39	-2.84671532847	13.7	18.49	11	1066985	14.53099064	CS
26	4.18	45.7831325301	9.13	18.49	7.55	982003	12.82794466	CS
52	8.55	179.621848739	4.76	18.49	4.64	764275	11.12957968	CS
156	8.03	152.083333333	5.28	18.49	2.55	712047	8.48968297	CS
260	8.03	152.083333333	5.28	18.49	2.55	712047	8.48968297	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
WORXSCWorx Corporation	US$ 2.0608 (110.29%)	94.07M
SKKSKK Holdings Limited	US$ 9.3536 (105.12%)	5.09M
CRNCCerence Inc	US$ 5.13 (81.91%)	20.31M
SURGSurgePays Inc	US$ 2.2241 (52.34%)	9.61M
IBGInnovation Beverage Group Limited	US$ 1.13 (42.82%)	2.34M
PYXSPyxis Oncology Inc	US$ 2.1099 (-44.77%)	8.26M
KURAKura Oncology Inc	US$ 9.91 (-37.71%)	6.78M
AGFYAgrify Corporation	US$ 25.83 (-33.36%)	313.42k
SHOTWSafety Shot Inc	US$ 0.1001 (-33.27%)	2.5k
BLRXBioLineRx Ltd	US$ 0.37 (-32.13%)	4.98M
CDTConduit Pharmaceuticals Inc	US$ 0.1238 (34.13%)	449M
AKTSAkoustis Technologies Inc	US$ 0.1049 (20.44%)	172.52M
NVDANVIDIA Corporation	US$ 141.93 (-2.71%)	155.86M
ELABElevai Labs Inc	US$ 0.0203 (-5.14%)	101.65M
WORXSCWorx Corporation	US$ 2.08 (112.24%)	93.18M